Table 3.
Inflammatory markers | CXCL9 |
CXCL10 |
CXCL11 |
|||
---|---|---|---|---|---|---|
Pearson correlation (49) |
||||||
r value | p value | r value | p value | r value | p value | |
CXCL9 | 1 | 0.235 | 0.075 | 0.285* | 0.029 | |
CXCL10 | 0.235 | 0.075 | 1 | 0.739** | 0.0001 | |
CXCL11 | 0.285* | 0.029 | 0.739** | 0.0001 | 1 | |
Interleukins | ||||||
IL-1β | 0.03 | 0.845 | 0.656** | 0.0001 | 0.516** | 0.0001 |
IL-2 | 0.044 | 0.745 | 0.229 | 0.089 | 0.426** | 0.001 |
IL-5 | 0.002 | 0.99 | −0.056 | 0.691 | 0.023 | 0.87 |
IL-6 | 0.008 | 0.956 | 0.504** | 0.0001 | 0.470** | 0.0001 |
IL-8 | −0.056 | 0.7 | 0.121 | 0.414 | 0.146 | 0.315 |
IL-12A | 0.034 | 0.826 | 0.199 | 0.211 | 0.285 | 0.068 |
IL-13 | 0.054 | 0.702 | −0.1 | 0.486 | −0.022 | 0.878 |
TNF-α | 0.1 | 0.472 | 0.427 ** | 0.002 | 0.450** | 0.001 |
CC chemokine ligands | ||||||
CCL2 | 0.132 | 0.327 | 0.546** | 0.0001 | 0.537** | 0.0001 |
CCL3 | −0.004 | 0.979 | 0.097 | 0.489 | 0.215 | 0.118 |
CCL5 | 0.121 | 0.417 | 0.264 | 0.076 | 0.468** | 0.001 |
CCL8 | 0.229 | 0.107 | 0.721 ** | 0.0001 | 0.501** | 0.0001 |
CCL7 | −0.04 | 0.77 | 0.125 | 0.368 | 0.174 | 0.204 |
CCL11 | 0.214 | 0.116 | 0.393** | 0.004 | 0.325* | 0.015 |
CCL15 | 0.211 | 0.108 | −0.03 | 0.822 | −0.106 | 0.428 |
CCL18 | 0.114 | 0.395 | 0.238 | 0.075 | 0.373** | 0.004 |
CCL19 | 0.233 | 0.082 | 0.272* | 0.045 | 0.489** | 0.0001 |
CCL20 | 0.051 | 0.704 | 0.516** | 0.0001 | 0.391** | 0.003 |
CCR2 | 0.255 | 0.068 | 0.582** | 0.0001 | 0.589** | 0.0001 |
CCR5 | 0.268* | 0.04 | 0.398** | 0.002 | 0.562** | 0.0001 |
Macrophage markers | ||||||
CD86 | 0.397** | 0.002 | 0.337* | 0.012 | 0.362** | 0.007 |
CD163 | 0.227 | 0.083 | 0.309* | 0.02 | 0.413** | 0.001 |
CXCLs, angiostatic chemokines; IL, interleukin; TNF-α, tumor necrosis factor alpha.
Bold values with statistically significant correlations as indicated with the prospective p-value column.